CIDRAP newsletters options
One study finds dramatically lower protection against infection—but not hospitalization or death—5 to 7 months after vaccination.
The plan aims to have 70% of each country's population vaccinated by mid-2022.
More than 140,000 US children lost a parent or other caregiver from COVID-19 during the pandemic, representing one caregiver loss for every four coronavirus deaths, suggests a modeling study today in Pediatrics.
"Keeping up with measures that suppress transmission are hard but even more critical now."
The risk ranged from 6.8% for people with tobacco use disorder to 7.8% for those with cannabis use disorder.
Aside from quadrupling the supply of home tests, officials say access will expand to free testing at community sites, which includes pharmacies.
Allocations and purchase limits for some treatments are rolling out across the US.
The World Health Organization (WHO) today recommended the RTS,S malaria vaccine for children in sub-Saharan Africa and other areas of moderate and high Plasmodium falciparum malaria transmission. The recommendation paves the way for global health groups to make funding and vaccine rollout plans and for countries to decide whether to include vaccination in their malaria control programs.
A US Department of Health and Human Services (HHS) analysis of Medicare data and county vaccination rates indicates that COVID-19 vaccinations administered from January until May 2021 were estimated to reduce COVID-19 infections by 265,000 and deaths by 39,000 among Medicare beneficiaries.
The vaccine is 90% effective against hospitalization caused by all variants, including Delta, for at least 6 months.
"We've really started to see the infectious disease community embrace the idea of phage therapy."
Though cases declined overall, the number of pediatric cases remains at high levels that have persisted since the school year started.
An analysis determines that the approach would be more cost-effective in the US than in China or India.
Though the continent lags well behind the rest of the world due to persistent supply inequity, it is making modest progress.
COVID-19 variants of concern (VOCs), especially the Delta (B1617.2) variant, are more virulent than the wild type, according to an Ontario-based study published in CMAJ yesterday. The cohort included 212,326 cases of non-VOCs (22.4%) and VOCs with the N501Y mutation (76.7%), such as Alpha (B117), Beta (B1351), Gamma (P1), and Delta.
A national ambulatory antibiotic stewardship program was associated with declines in overall and acute respiratory infection (ARI)-related prescribing during the COVID-19 pandemic, US researchers reported last week at ID Week 2021.
Report says the supply chain needs more assessment, and mitigation steps must be fully developed.
Also, the persistence of depressive symptoms for more than 1 year was greater than after the Sep 11 attacks.
Though the Delta surge appears to be ebbing, several states are still experiencing overcrowded hospitals.
In other global developments, New Zealand announces a plan to loosen restrictions as Delta cases pop up in new parts of Australia.
